NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

治療用BCG疫苗的全球市場:各類型,人口動態,各終端用戶的預測(到2025年)- COVID-19累積的影響

Therapeutic BCG Vaccine Market Research Report by Type, by Demographics, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1005151
出版日期 內容資訊 英文 194 Pages
商品交期: 最快1-2個工作天內
價格
治療用BCG疫苗的全球市場:各類型,人口動態,各終端用戶的預測(到2025年)- COVID-19累積的影響 Therapeutic BCG Vaccine Market Research Report by Type, by Demographics, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 194 Pages
簡介

全球治療用BCG疫苗的市場規模預計將從2020年的5,108萬美元,擴大到2025年末的6,059萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察,分析,與預測。

本報告提供全球治療用BCG疫苗市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,類型·人口動態·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查的成果

第3章 摘要整理

  • 市場預測
  • 終端用戶預測
  • 各類型市場展望
  • 各人口動態市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各類型市場

  • 免疫BCG
  • 治療用BCG

第7章 各人口動態市場

  • 成人
  • 兒童

第8章 各終端用戶市場

  • 診所
  • 醫院

第9章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併·收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第13章 企業簡介

  • AJ Vaccines
  • China National Biotec Group
  • Green Signal Bio Pharma Pvt Ltd
  • GREENSIGNAL BIO PHARMA LIMITED
  • InterVax Ltd.
  • Japan BCG Laboratory
  • Merck & Co., Inc.
  • Sanofi Pasteur
  • Serum Institute of India Private Limited
  • Statens Serum Institut

第14章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-030298DFF713

The Global Therapeutic BCG Vaccine Market size was estimated at USD 51.08 Million in 2020 and expected to reach USD 53.11 Million in 2021, at a Compound Annual Growth Rate (CAGR) 4.31% to reach USD 65.80 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Therapeutic BCG Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Therapeutic BCG Vaccine Market was studied across Immune BCG and Therapy BCG.

Based on Demographics, the Therapeutic BCG Vaccine Market was studied across Adults and Pediatrics.

Based on End User, the Therapeutic BCG Vaccine Market was studied across Clinics and Hospitals.

Based on Geography, the Therapeutic BCG Vaccine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Therapeutic BCG Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Therapeutic BCG Vaccine Market, including AJ Vaccines, China National Biotec Group, Green Signal Bio Pharma Pvt Ltd, GREENSIGNAL BIO PHARMA LIMITED, InterVax Ltd., Japan BCG Laboratory, Merck & Co., Inc., Sanofi Pasteur, Serum Institute of India Private Limited, and Statens Serum Institut.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Therapeutic BCG Vaccine Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Therapeutic BCG Vaccine Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Therapeutic BCG Vaccine Market?
  • 4. What is the competitive strategic window for opportunities in the Global Therapeutic BCG Vaccine Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Therapeutic BCG Vaccine Market?
  • 6. What is the market share of the leading vendors in the Global Therapeutic BCG Vaccine Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Therapeutic BCG Vaccine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. End User Outlook
  • 3.4. Type Outlook
  • 3.5. Demographics Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing advancement in the pediatric care
      • 5.1.1.2. High investment in research & development of therapeutic BCG vaccine
      • 5.1.1.3. Increasing awareness through campaign
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of therapeutic BCG vaccine
    • 5.1.3. Opportunities
      • 5.1.3.1. Untapped market in developing and underdeveloped countries
      • 5.1.3.2. Growing initiatives by United Nations (UN) for TB preventions
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with BCG vaccine
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Therapeutic BCG Vaccine Market, by Type

  • 6.1. Introduction
  • 6.2. Immune BCG
  • 6.3. Therapy BCG

7. Therapeutic BCG Vaccine Market, by Demographics

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Pediatrics

8. Therapeutic BCG Vaccine Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Therapeutic BCG Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Therapeutic BCG Vaccine Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Therapeutic BCG Vaccine Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AJ Vaccines
  • 13.2. China National Biotec Group
  • 13.3. Green Signal Bio Pharma Pvt Ltd
  • 13.4. GREENSIGNAL BIO PHARMA LIMITED
  • 13.5. InterVax Ltd.
  • 13.6. Japan BCG Laboratory
  • 13.7. Merck & Co., Inc.
  • 13.8. Sanofi Pasteur
  • 13.9. Serum Institute of India Private Limited
  • 13.10. Statens Serum Institut

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL THERAPEUTIC BCG VACCINE MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL THERAPEUTIC BCG VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2026
  • FIGURE 11. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY IMMUNE BCG, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY IMMUNE BCG, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY THERAPY BCG, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY THERAPY BCG, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2020 VS 2026 (%)
  • FIGURE 16. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2026
  • FIGURE 18. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ADULTS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ADULTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PEDIATRICS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PEDIATRICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 23. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2026
  • FIGURE 25. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 30. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 32. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. CALIFORNIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. FLORIDA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. ILLINOIS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. NEW YORK THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. OHIO THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. PENNSYLVANIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. TEXAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 45. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 47. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 56. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 58. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. GLOBAL THERAPEUTIC BCG VACCINE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 71. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL THERAPEUTIC BCG VACCINE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL THERAPEUTIC BCG VACCINE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY IMMUNE BCG, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY THERAPY BCG, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ADULTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PEDIATRICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. CALIFORNIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. CALIFORNIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. CALIFORNIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. FLORIDA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. FLORIDA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. FLORIDA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ILLINOIS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ILLINOIS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ILLINOIS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. NEW YORK THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. NEW YORK THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. NEW YORK THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. OHIO THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. OHIO THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. OHIO THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. PENNSYLVANIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. PENNSYLVANIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. PENNSYLVANIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. TEXAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. TEXAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. TEXAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SCORES
  • TABLE 119. GLOBAL THERAPEUTIC BCG VACCINE MARKET: BUSINESS STRATEGY
  • TABLE 120. GLOBAL THERAPEUTIC BCG VACCINE MARKET: PRODUCT SATISFACTION
  • TABLE 121. GLOBAL THERAPEUTIC BCG VACCINE MARKET: RANKING
  • TABLE 122. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 123. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SHARE, BY COMPANY, 2020
  • TABLE 124. GLOBAL THERAPEUTIC BCG VACCINE MARKET: MERGER & ACQUISITION
  • TABLE 125. GLOBAL THERAPEUTIC BCG VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 126. GLOBAL THERAPEUTIC BCG VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 127. GLOBAL THERAPEUTIC BCG VACCINE MARKET: INVESTMENT & FUNDING
  • TABLE 128. GLOBAL THERAPEUTIC BCG VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 129. GLOBAL THERAPEUTIC BCG VACCINE MARKET: LICENSE & PRICING
  • TABLE 130. GLOBAL THERAPEUTIC BCG VACCINE MARKET: CONTACT DETAILS